Clinical Trial Update: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating allogeneic mesenchymal stem cells for lupus nephritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Lupus Nephritis, Lupus Erythematosus | Phase 2 | Status: RECRUITING